ArticleBlood advances2023

Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapy.

Michael A Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.